tiprankstipranks
Advertisement
Advertisement

EVGN Stock Latest News

Evogene price target lowered to $2.15 from $2.25 at Alliance Global
The FlyEvogene price target lowered to $2.15 from $2.25 at Alliance Global
5d ago
EVGN
Evogene Earnings Call: AI Momentum vs. Cash Strain
PremiumCompany Announcements
Evogene Earnings Call: AI Momentum vs. Cash Strain
11d ago
EVGN
Evogene Tightens Focus on AI Small-Molecule Platform as Q1 2026 Revenue Falls
PremiumCompany Announcements
Evogene Tightens Focus on AI Small-Molecule Platform as Q1 2026 Revenue Falls
11d ago
6K
EVGN
Evogene reporta Q1 cont. ops. EPS (60c) vs. (26c) last year
PremiumThe Fly
Evogene reporta Q1 cont. ops. EPS (60c) vs. (26c) last year
11d ago
EVGN
Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short
PremiumCompany Announcements
Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short
13d ago
6K
EVGN
Evogene price target raised to $2.25 from $1.75 at Alliance Global
PremiumThe FlyEvogene price target raised to $2.25 from $1.75 at Alliance Global
2M ago
EVGN
Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026
Premium
Company Announcements
Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026
2M ago
6K
EVGN
Evogene receives Nasdaq minimum bid price notification
Premium
The Fly
Evogene receives Nasdaq minimum bid price notification
2M ago
EVGN
Evogene files to sell 5.08M ordinary shares for holders
PremiumThe Fly
Evogene files to sell 5.08M ordinary shares for holders
2M ago
EVGN
Evogene price target lowered to $1.75 from $2.50 at Alliance Global
PremiumThe Fly
Evogene price target lowered to $1.75 from $2.50 at Alliance Global
3M ago
EVGN
Evogene Earnings Call: AI Ambition Meets Cash Reality
PremiumCompany Announcements
Evogene Earnings Call: AI Ambition Meets Cash Reality
3M ago
EVGN
Evogene Reshapes AI-Driven Molecule Business With 2025 Results and Strategic Overhaul
PremiumCompany Announcements
Evogene Reshapes AI-Driven Molecule Business With 2025 Results and Strategic Overhaul
3M ago
6K
EVGN
Evogene reports Q4 cont ops EPS (61c) vs. 17c last year
PremiumThe FlyEvogene reports Q4 cont ops EPS (61c) vs. 17c last year
3M ago
EVGN
EVGN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
EVGN Earnings this Week: How Will it Perform?
3M ago
EVGN
Evogene Details 2025 Strategic Refocus Around ChemPass AI and Core Health, Agriculture Markets
Premium
Company Announcements
Evogene Details 2025 Strategic Refocus Around ChemPass AI and Core Health, Agriculture Markets
3M ago
6K
EVGN
Evogene collaborates with Queensland University in AI-driven cancer therapeutics
PremiumThe Fly
Evogene collaborates with Queensland University in AI-driven cancer therapeutics
3M ago
EVGN
Evogene Secures $3.4 Million Through Warrant Inducement Deal
PremiumCompany Announcements
Evogene Secures $3.4 Million Through Warrant Inducement Deal
4M ago
6K
EVGN
Evogene expands collaboration with Google Cloud for AI agents into ChemPass AI
PremiumThe Fly
Evogene expands collaboration with Google Cloud for AI agents into ChemPass AI
4M ago
EVGN
GOOG
Evogene, Shanghai Lishan Biopharmaceuticals enter BMC128 licensing agreement
PremiumThe Fly
Evogene, Shanghai Lishan Biopharmaceuticals enter BMC128 licensing agreement
4M ago
EVGN
Evogene’s Biomica Grants Lishan Biotech Global Rights to Microbiome Cancer Drug BMC128
PremiumCompany AnnouncementsEvogene’s Biomica Grants Lishan Biotech Global Rights to Microbiome Cancer Drug BMC128
4M ago
6K
EVGN
Biomica and Lishan Biotech sign licensing agreement for BMC128
Premium
The Fly
Biomica and Lishan Biotech sign licensing agreement for BMC128
4M ago
EVGN
Evogene Announces CFO Resignation and Finance Leadership Transition
Premium
Company Announcements
Evogene Announces CFO Resignation and Finance Leadership Transition
5M ago
6K
EVGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >